HORSHAM, Pa., Sept. 19 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) announced today that it will present at the UBS Global Life Sciences Conference being held at the Grand Hyatt in New York City from September 26-29, 2005. C. Boyd Clarke, Neose's president, chief executive officer and chairman, will present at 9:30 a.m. (EDT) on Monday, September 26, 2005. The presentation will be webcast live and available for replay via the following link: http://event.streamx.us/event/20050926 The webcast will also be available on the Investor Relations/Audio Archives page of the Company's website, http://www.neose.com/.
Neose is a biopharmaceutical company using its proprietary enzymatic technologies to develop improved drugs, focusing primarily on therapeutic proteins. Neose uses its GlycoAdvance(R) and GlycoPEGylation(TM) technologies to develop improved versions of drugs with proven safety and efficacy. Neose intends to apply its technologies to products it is developing on its own and to products it co-develops and co-owns with others. It also expects to make its technologies available, through strategic partnerships, to improve the products of other parties. Neose's first two proprietary candidates are NE-180 (GlycoPEG-EPO), a long-acting version of erythropoietin, and GlycoPEG- GCSF, a long-acting version of granulocyte colony stimulating factor (G-CSF).
CONTACTS:
Neose Technologies, Inc. A. Brian Davis
Sr. Vice President and Chief Financial Officer
Barbara Krauter
Manager, Investor Relations
(215) 315-9000 For more information, please visit http://www.neose.com/. DATASOURCE: Neose Technologies, Inc.
CONTACT: A. Brian Davis, Sr. Vice President and Chief Financial Officer or Barbara Krauter, Manager, Investor Relations, both of Neose Technologies, Inc., +1-215-315-9000 Web site: http://event.streamx.us/event/20050926 Web site: http://www.neose.com/
|